☆ 4.2 Review

Management of Pulmonary Arterial Hypertension

SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2023)

Related references

Note: Only part of the references are listed.

Article Critical Care Medicine

The Lung Allocation Score Remains Inequitable for Patients with Pulmonary Arterial Hypertension, Even after the 2015 Revision

Nicholas A. Kolaitis et al.

Summary: The 2015 revision of the lung allocation score (LAS) aimed to improve waiting list mortality and transplant rates for patients with pulmonary arterial hypertension (PAH). A study comparing the pre- and post-revision eras found that the revision did achieve its intended goals, providing better transplantation opportunities and reducing the risk of death on the waiting list for patients with PAH.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2023)

Add to Collection

Article Respiratory System

2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

Marc Humbert et al.

EUROPEAN RESPIRATORY JOURNAL (2023)

Add to Collection

Article Respiratory System

Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension

Marc Humbert et al.

Summary: In participants with pulmonary arterial hypertension, 24 weeks of sotatercept resulted in a significant reduction in pulmonary vascular resistance. This study reports the longer-term safety and efficacy of sotatercept in the PULSAR open-label extension, showing that sotatercept has good safety and efficacy in patients with pulmonary arterial hypertension.

EUROPEAN RESPIRATORY JOURNAL (2023)

Add to Collection

Article Medicine, General & Internal

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension

Marius M. Hoeper et al.

Summary: This study confirms that in patients with stable background therapy, sotatercept can significantly improve the exercise capacity of patients with pulmonary arterial hypertension compared to placebo.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

Add to Collection

Article Respiratory System

COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension

Marius M. Hoeper et al.

Summary: The study investigated a modified risk stratification approach based on four risk categories, using refined cutoff levels for functional class, 6MWD, and BNP/NT-proBNP. The four-stratum model was found to be more sensitive in predicting long-term survival and prognostic changes compared to the original three-stratum model.

EUROPEAN RESPIRATORY JOURNAL (2022)

Add to Collection

Article Respiratory System

External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry

Athenais Boucly et al.

Summary: This study validated a four-stratum risk assessment approach for patients with pulmonary arterial hypertension (PAH). Compared to a three-stratum approach, the four-stratum method performed better in predicting mortality and was more sensitive to changes in risk status. It also provided more refined risk categories for different subgroups of PAH patients.

EUROPEAN RESPIRATORY JOURNAL (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Upfront riociguat and ambrisentan combination therapy for newly diagnosed pulmonary arterial hypertension: A prospective open-label trial

Jason Weatherald et al.

Summary: This study suggests that the combination therapy of riociguat and ambrisentan has limited efficacy in initial treatment of pulmonary arterial hypertension (PAH) patients. After 4 months of treatment, pulmonary vascular resistance (PVR) decreased and other hemodynamic variables and risk scores improved.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2022)

Add to Collection

Article Critical Care Medicine

COVID-19 in Patients with Pulmonary Hypertension A National Prospective Cohort Study

David Montani et al.

Summary: COVID-19 in patients with precapillary PH was associated with a high in-hospital mortality. The typical risk factors for severe COVID-19 and severity of PH were associated with mortality in this population.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

Add to Collection

Article Respiratory System

The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner?

Roberto Badagliacca et al.

Summary: This study investigated the impact of COVID-19 on PAH management and outcomes. It found that remote monitoring led to lower hospitalization rates and related mortality, but there were also risks of less aggressive treatment escalation and reduced new PAH diagnoses.

EUROPEAN RESPIRATORY JOURNAL (2022)

Add to Collection

Article Pediatrics

Pulmonary hypertension in pregnancy and its effects on the fetus

Brie Ann Muller et al.

Summary: Pulmonary hypertension is an important and potentially lethal diagnosis for pregnant patients. Recent studies have shown improved maternal outcomes with early multidisciplinary treatment. Pregnant patients with PH require specialized management, and echocardiography is an important tool for monitoring cardiac function.

SEMINARS IN FETAL & NEONATAL MEDICINE (2022)

Add to Collection

Article Medicine, General & Internal

The evolving landscape of pulmonary arterial hypertension clinical trials

Jason Weatherald et al.

LANCET (2022)

Add to Collection

Article Critical Care Medicine

Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis

Marius M. Hoeper et al.

Summary: This study provides a detailed characterization of patients meeting diagnostic criteria for idiopathic pulmonary arterial hypertension (IPAH) and identifies a distinct lung phenotype characterized by low diffusion capacity for carbon monoxide (DLCO) and smoking history. These patients resemble those with pulmonary hypertension due to lung disease rather than classical IPAH. These findings have important implications for understanding the pathogenesis, diagnosis, and treatment of the disease and warrant further exploration.

LANCET RESPIRATORY MEDICINE (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG)

Marc Humbert et al.

EUROPEAN HEART JOURNAL (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

INSPIRE: Safety and tolerability of inhaled Yutrepia (treprostinil) in pulmonary arterial hypertension (PAH)

Nicholas S. Hill et al.

Summary: The INSPIRE trial assessed the safety and efficacy of Yutrepia in patients with pulmonary arterial hypertension. Comparing the transition group and the prostacyclin naive group, Yutrepia was found to be a convenient, safe, and well-tolerated treatment option for patients with pulmonary arterial hypertension.

PULMONARY CIRCULATION (2022)

Add to Collection

Review Respiratory System

A Systematic Evaluation of the Quality, Accuracy, and Reliability of Internet Websites about Pulmonary Arterial Hypertension

Dana Saleh et al.

Summary: The quality and reliability of websites on pulmonary arterial hypertension (PAH) is generally low, with only a few websites providing accurate and comprehensive information. However, there are some high-quality websites that can be useful for patients, caregivers, and clinicians.

ANNALS OF THE AMERICAN THORACIC SOCIETY (2022)

Add to Collection

Article Critical Care Medicine

Development and Validation of an Abridged Version of the REVEAL 2.0 Risk Score Calculator, REVEAL Lite 2, for Use in Patients With Pulmonary Arterial Hypertension

Raymond L. Benza et al.

Summary: REVEAL Lite 2, a simplified version of REVEAL 2.0, provides a convenient method for risk assessment in PAH patients. It includes six noninvasive variables and effectively discriminates among low, intermediate, and high-risk patients for 1-year mortality, showing promise for routine clinical implementation.

CHEST (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial

Ekkehard Gruenig et al.

Summary: This study demonstrated that exercise training for patients with PAH and CTEPH can significantly improve quality of life, WHO functional class, and peak oxygen consumption, and is feasible, safe, and well-tolerated as an add-on to medical therapy.

EUROPEAN HEART JOURNAL (2021)

Add to Collection

Article Respiratory System

Screening for pulmonary arterial hypertension in adults carrying a BMPR2 mutation

David Montani et al.

Summary: This study evaluated the characteristics and risk of developing PAH in asymptomatic BMPR2 mutation carriers, aiming to detect PAH at an early stage in this high-risk population. The results showed that asymptomatic BMPR2 mutation carriers have a significant risk of developing incident PAH, highlighting the importance of regular screening programs for early detection.

EUROPEAN RESPIRATORY JOURNAL (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Pregnancy in pulmonary arterial hypertension: Midterm outcomes of mothers and offspring

Jan C. Kamp et al.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Three- Versus Two-Drug Therapy for Patients With Newly Diagnosed Pulmonary Arterial Hypertension

Kelly M. Chin et al.

Summary: The study compared the efficacy and safety of initial triple oral therapy with initial double oral therapy in newly diagnosed PAH patients, finding that both treatment strategies were equally effective in reducing pulmonary vascular resistance, but initial triple oral therapy may potentially improve long-term outcomes.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)

Add to Collection

Review Medicine, General & Internal

Pulmonary Arterial Hypertension

Paul M. Hassoun

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Riociguat treatment in patients with pulmonary arterial hypertension: Final safety data from the EXPERT registry

Marius M. Hoeper et al.

Summary: The EXPERT study monitored the long-term safety of riociguat in clinical practice, showing consistent safety with clinical trials and no new safety concerns, with a lower exposure-adjusted rate of hemoptysis/pulmonary hemorrhage compared to the Phase 3 trial in PAH.

RESPIRATORY MEDICINE (2021)

Add to Collection

Article Respiratory System

Sex and gender in pulmonary arterial hypertension

Celine Cheron et al.

Summary: Pulmonary arterial hypertension is a rare disease characterized by pulmonary vascular remodeling and elevated pulmonary pressure, with a female predominance. Several mechanisms, including estrogen signaling pathways and BMPR2 mutation, contribute to the pathogenesis of PAH, specifically in women. Women generally have better prognosis and right ventricular function in PAH, and may respond differently to treatment, necessitating particular attention to contraception and pregnancy management.

EUROPEAN RESPIRATORY REVIEW (2021)

Add to Collection

Article Immunology

COVID-19 Vaccination in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Safety Profile and Reasons for Opting against Vaccination

Maria Wieteska-Milek et al.

Summary: The incidence of COVID-19 infection in patients with PAH and CTEPH is similar to that in the general population, but the mortality rate is higher. COVID-19 vaccination is recommended for these patients. Some patients refused vaccination due to concerns about adverse events and age had an impact on willingness to be vaccinated. Adverse events were more common in younger patients, but the vaccines were overall considered safe for PAH/CTEPH patients.

VACCINES (2021)

Add to Collection

Article Medicine, General & Internal

Sotatercept for the Treatment of Pulmonary Arterial Hypertension

Marc Humbert et al.

Summary: In this study, patients with pulmonary arterial hypertension receiving Sotatercept treatment showed a significant reduction in pulmonary vascular resistance at 24 weeks, with both Sotatercept groups performing better than the placebo group.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Critical Care Medicine

Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial

Marius M. Hoeper et al.

Summary: The study compared the effects of switching to riociguat from PDE5i therapy versus continuing PDE5i therapy in PAH patients at intermediate risk of 1-year mortality. Results showed higher clinical improvement rates and lower clinical worsening events in the riociguat group, indicating that switching to riociguat could be a strategic treatment escalation option for these patients.

LANCET RESPIRATORY MEDICINE (2021)

Add to Collection

Article Critical Care Medicine

Association between Initial Treatment Strategy and Long-Term Survival in Pulmonary Arterial Hypertension

Athenais Boucly et al.

Summary: The study findings suggest that initial triple combination therapy containing parenteral prostacyclin is associated with a higher survival rate in patients with PAH, particularly in younger high-risk patients.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation

Lorriana E. Leard et al.

Summary: Lung transplant is a crucial treatment option for patients with advanced lung diseases, but there are challenges and ethical dilemmas in the process of referral, evaluation, and candidacy determination. The International Society for Heart and Lung Transplantation has updated consensus documents to assist providers in identifying, evaluating, and selecting potential candidates for lung transplant, addressing ethical considerations, and acknowledging variability in risk acceptance among transplant centers.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2021)

Add to Collection

Article Psychiatry

Prevalence of Mental Disorders and Impact on Quality of Life in Patients With Pulmonary Arterial Hypertension

Karen M. Olsson et al.

Summary: The study found that mental disorders are quite common in patients with PAH and have a significant impact on their quality of life. Adjustment disorder, major depression, and panic disorder are the most common mental illnesses among these patients. The Hospital Anxiety and Depression Scale can be used as a screening tool for common mental health disorders.

FRONTIERS IN PSYCHIATRY (2021)

Add to Collection

Article Medicine, General & Internal

Favorable Pregnancy Outcomes in Women With Well-Controlled Pulmonary Arterial Hypertension

Nadine Corbach et al.

Summary: This study retrospectively analyzed seven pregnancies of five women with PAH, showing that these women had favorable outcomes during and after pregnancy, resulting in successful deliveries of healthy newborns.

FRONTIERS IN MEDICINE (2021)

Add to Collection

Article Respiratory System

Depression, anxiety and psychological distress in patients with pulmonary hypertension: a mixed-methods study

Yuka Takita et al.

Summary: The study revealed that PH patients are prone to depression, with PAH patients showing particularly high levels of depressive symptoms. Qualitative interview data extracted themes such as "Loss of myself" and "Isolation from my surroundings." Identifying factors and themes influencing the psychological distress of PH patients is crucial for improving support for their physical and mental health.

BMJ OPEN RESPIRATORY RESEARCH (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial

Ekkehard Gruenig et al.

Summary: This study is the first multicentre and largest randomized, controlled study on the feasibility, safety, and efficacy of exercise training as add-on to medical therapy in PAH and CTEPH patients, showing that exercise training can improve patients' exercise capacity, quality of life, and WHO functional class.

EUROPEAN HEART JOURNAL (2021)

Add to Collection

Article Critical Care Medicine

Risk Reduction and Right Heart Reverse Remodeling by Upfront Triple Combination Therapy in Pulmonary Arterial Hypertension

Michele D'Alto et al.

CHEST (2020)

Add to Collection

Article Critical Care Medicine

Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension A Double-Blind Placebo-controlled Clinical Trial

R. James White et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)

Add to Collection

Letter Respiratory System

Transition from intravenous epoprostenol to selexipag in pulmonary arterial hypertension: a word of caution

Kenichi Yanaka et al.

EUROPEAN RESPIRATORY JOURNAL (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Experience in Transitioning From Parenteral Prostacyclins to Selexipag in Pulmonary Arterial Hypertension

Kishan S. Parikh et al.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2020)

Add to Collection

Letter Respiratory System

Initial combination therapy of macitentan and tadalafil in pulmonary arterial hypertension

Olivier Sitbon et al.

EUROPEAN RESPIRATORY JOURNAL (2020)

Add to Collection

Article Medicine, General & Internal

Pregnancy outcomes in patients with pulmonary arterial hypertension A retrospective study

Jun Luo et al.

MEDICINE (2020)

Add to Collection

Review Obstetrics & Gynecology

Pulmonary hypertension and pregnancy outcomes: Systematic Review and Meta-analysis

Nivedita Jha et al.

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry

Marius M. Hoeper et al.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2020)

Add to Collection

Review Hematology

Can anticoagulants improve the survival rate for patients with idiopathic pulmonary arterial hypertension? A systematic review and meta-analysis

Peijie Wang et al.

THROMBOSIS RESEARCH (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Transitions between infused and oral prostacyclin pathway agents in pulmonary arterial hypertension: key considerations

Therese Sargent et al.

PULMONARY CIRCULATION (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Safety and tolerability of transition from inhaled treprostinil to oral selexipag in pulmonary arterial hypertension: Results from the TRANSIT-1 study

Adaani Frost et al.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2019)

Add to Collection

Article Obstetrics & Gynecology

Outcome of pregnancies in women with pulmonary hypertension: a single-centre experience from South India

A. Keepanasseril et al.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2019)

Add to Collection

Article Critical Care Medicine

Predicting Survival in Patients With Pulmonary Arterial Hypertension The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment Strategies

Raymond L. Benza et al.

CHEST (2019)

Add to Collection

Review Hematology

Indications and potential pitfalls of anticoagulants in pulmonary hypertension: Would DOACs become a better option than VKAs?

Victor Margelidon-Cozzolino et al.

BLOOD REVIEWS (2019)

Add to Collection

Article Respiratory System

Effect of domiciliary oxygen therapy on exercise capacity and quality of life in patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension: a randomised, placebo-controlled trial

Silvia Ulrich et al.

EUROPEAN RESPIRATORY JOURNAL (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

Patients with pulmonary arterial hypertension with and without cardiovascular risk factors: Results from the AMBITION trial

Vallerie V. McLaughlin et al.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

Extracorporeal life support bridge for pulmonary hypertension: A high-volume single-center experience

Erika B. Rosenzweig et al.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult heart transplantation report-2019; focus theme: Donor and recipient size match

Kiran K. Khush et al.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2019)

Add to Collection

Article Respiratory System

Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives

Marc Humbert et al.

EUROPEAN RESPIRATORY JOURNAL (2019)

Add to Collection

Article Respiratory System

Genetics and genomics of pulmonary arterial hypertension

Nicholas W. Morrell et al.

EUROPEAN RESPIRATORY JOURNAL (2019)

Add to Collection

Article Respiratory System

Haemodynamic definitions and updated clinical classification of pulmonary hypertension

Gerald Simonneau et al.

EUROPEAN RESPIRATORY JOURNAL (2019)

Add to Collection

Article Respiratory System

Risk stratification and medical therapy of pulmonary arterial hypertension

Nazzareno Galie et al.

EUROPEAN RESPIRATORY JOURNAL (2019)

Add to Collection

Article Respiratory System

Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension

Marius M. Hoeper et al.

EUROPEAN RESPIRATORY JOURNAL (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

Clinical and hemodynamic benefit of macitentan and riociguat upfront combination in patients with pulmonary arterial hypertension

Roxana Sulica et al.

PULMONARY CIRCULATION (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

Transition from parental prostacyclin to selexipag: a case series of five pulmonary arterial hypertension patients

Nathan Holthaus et al.

PULMONARY CIRCULATION (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension

David Kylhammar et al.

EUROPEAN HEART JOURNAL (2018)

Add to Collection

Article Cardiac & Cardiovascular Systems

Targeting the Prostacyclin Pathway with Selexipag in Patients with Pulmonary Arterial Hypertension Receiving Double Combination Therapy: Insights from the Randomized Controlled GRIPHON Study

J. Gerry Coghlan et al.

AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2018)

Add to Collection

Editorial Material Respiratory System

Age, risk and outcomes in idiopathic pulmonary arterial hypertension

Marius M. Hoeper et al.

EUROPEAN RESPIRATORY JOURNAL (2018)

Add to Collection

Article Respiratory System

Impact of age and comorbidity on risk stratification in idiopathic pulmonary arterial hypertension

Clara Hjalmarsson et al.

EUROPEAN RESPIRATORY JOURNAL (2018)

Add to Collection

Article Psychiatry

Impact of psychological factors on the health-related quality of life of patients treated for pulmonary arterial hypertension

Laurence Halimi et al.

JOURNAL OF PSYCHOSOMATIC RESEARCH (2018)

Add to Collection

Article Cardiac & Cardiovascular Systems

Extracorporeal life support as a bridge to lung transplantation-experience of a high-volume transplant center

Konrad Hoetzenecker et al.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2018)

Add to Collection

Review Immunology

Cardioprotective effect of influenza and pneumococcal vaccination in patients with cardiovascular diseases

Andrzej Ciszewski

VACCINE (2018)

Add to Collection

Review Cardiac & Cardiovascular Systems

Is Anticoagulation Beneficial in Pulmonary Arterial Hypertension? A Systematic Review and Meta-Analysis

Muhammad Shahzeb Khan et al.

CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2018)

Add to Collection

Article Respiratory System

Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertension

Jason Weatherald et al.

EUROPEAN RESPIRATORY JOURNAL (2018)

Add to Collection

Article Pharmacology & Pharmacy

Transition from treprostinil to selexipag in patients with pulmonary arterial hypertension: Case series

Sherif M. Fanous et al.

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2018)

Add to Collection

Review Peripheral Vascular Disease

Anxiety and depression in patients with pulmonary hypertension: impact and management challenges

Maurizio Bussotti et al.

VASCULAR HEALTH AND RISK MANAGEMENT (2018)

Add to Collection

Article Rheumatology

Riociguat for the treatment of pulmonary arterial hypertension associated with connective tissue disease: results from PATENT-1 and PATENT-2

Marc Humbert et al.

ANNALS OF THE RHEUMATIC DISEASES (2017)

Add to Collection

Review Obstetrics & Gynecology

Sildenafil in Pregnancy: A Systematic Review of Maternal Tolerance and Obstetric and Perinatal Outcomes

Liam Dunn et al.

FETAL DIAGNOSIS AND THERAPY (2017)

Add to Collection

Article Cardiac & Cardiovascular Systems

Effect of breathing oxygen-enriched air on exercise performance in patients with precapillary pulmonary hypertension: randomized, sham-controlled cross-over trial

Silvia Ulrich et al.

EUROPEAN HEART JOURNAL (2017)

Add to Collection

Letter Respiratory System

The potential effects of pregnancy in a patient with idiopathic pulmonary arterial hypertension responding to calcium channel blockade

Samuel Bostock et al.

EUROPEAN RESPIRATORY JOURNAL (2017)

Add to Collection

Article Respiratory System

Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model

Marius M. Hoeper et al.

EUROPEAN RESPIRATORY JOURNAL (2017)

Add to Collection

Article Respiratory System

Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension

Athenais Boucly et al.

EUROPEAN RESPIRATORY JOURNAL (2017)

Add to Collection

Article Respiratory System

Upfront combination therapy reduces right ventricular volumes in pulmonary arterial hypertension

Marielle C. van de Veerdonk et al.

EUROPEAN RESPIRATORY JOURNAL (2017)

Add to Collection

Review Cardiac & Cardiovascular Systems

Epidemiology and treatment of pulmonary arterial hypertension

Edmund M. T. Lau et al.

NATURE REVIEWS CARDIOLOGY (2017)

Add to Collection

Article Respiratory System

Clinical Risk Factors and Prognostic Model for Primary Graft Dysfunction after Lung Transplantation in Patients with Pulmonary Hypertension

Mary K. Porteous et al.

ANNALS OF THE AMERICAN THORACIC SOCIETY (2017)

Add to Collection

Article Cardiac & Cardiovascular Systems

Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial

Nicola Ehlken et al.

EUROPEAN HEART JOURNAL (2016)

Add to Collection

Article Critical Care Medicine

Critical Genomic Networks and Vasoreactive Variants in Idiopathic Pulmonary Arterial Hypertension

Anna R. Hemnes et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)

Add to Collection

Article Pharmacology & Pharmacy

Pharmacokinetics of the novel oral prostacyclin receptor agonist selexipag in subjects with hepatic or renal impairment

Priska Kaufmann et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)

Add to Collection

Review Public, Environmental & Occupational Health

Comparative Safety and Tolerability of Prostacyclins in Pulmonary Hypertension

Caroline O'Connell et al.

DRUG SAFETY (2016)

Add to Collection

Article Cardiac & Cardiovascular Systems

Pulmonary hypertension and pregnancy outcomes: data from the Registry Of Pregnancy and Cardiac Disease (ROPAC) of the European Society of Cardiology

Karen Sliwa et al.

EUROPEAN JOURNAL OF HEART FAILURE (2016)

Add to Collection

Article Respiratory System

Initial dual oral combination therapy in pulmonary arterial hypertension

Olivier Sitbon et al.

EUROPEAN RESPIRATORY JOURNAL (2016)

Add to Collection

Review Respiratory System

Pregnancy in pulmonary arterial hypertension

Karen M. Olsson et al.

EUROPEAN RESPIRATORY REVIEW (2016)

Add to Collection

Article Cardiac & Cardiovascular Systems

Pharmacokinetics and Tolerability of the Novel Oral Prostacyclin IP Receptor Agonist Selexipag

Priska Kaufmann et al.

AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2015)

Add to Collection

Article Critical Care Medicine

Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension

Paul M. Hassoun et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)

Add to Collection

Article Cardiac & Cardiovascular Systems

Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL)

Ioana R. Preston et al.

CIRCULATION (2015)

Add to Collection

Article Respiratory System

Riociguat for the treatment of pulmonary arterial hypertension: a long-term extension study (PATENT-2)

Lewis J. Rubin et al.

EUROPEAN RESPIRATORY JOURNAL (2015)

Add to Collection

Article Respiratory System

PATENT PLUS: a blinded, randomised and extension study of riociguat plus sildenafil in pulmonary arterial hypertension

Nazzareno Galie et al.

EUROPEAN RESPIRATORY JOURNAL (2015)

Add to Collection

Article Respiratory System

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

Nazzareno Galie et al.

EUROPEAN RESPIRATORY JOURNAL (2015)

Add to Collection

Article Cardiac & Cardiovascular Systems

Riociguat for pulmonary arterial hypertension associated with congenital heart disease

Stephan Rosenkranz et al.

HEART (2015)

Add to Collection

Article Medicine, General & Internal

Selexipag for the Treatment of Pulmonary Arterial Hypertension

Olivier Sitbon et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Add to Collection

Article Medicine, General & Internal

Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension

N. Galie et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Add to Collection

Review Respiratory System

Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease

Antoni Torres et al.

THORAX (2015)

Add to Collection

Article Respiratory System

Riociguat for the treatment of pulmonary hypertension

Nathan Hambly et al.

EXPERT REVIEW OF RESPIRATORY MEDICINE (2015)

Add to Collection

Article Cardiac & Cardiovascular Systems

Statement on pregnancy in pulmonary hypertension from the Pulmonary Vascular Research Institute

Anna R. Hemnes et al.

PULMONARY CIRCULATION (2015)

Add to Collection

Article Cardiac & Cardiovascular Systems

Peripheral Blood Signature of Vasodilator-Responsive Pulmonary Arterial Hypertension

Anna R. Hemnes et al.

CIRCULATION (2015)

Add to Collection

Article Cardiac & Cardiovascular Systems

Two formulations of epoprostenol sodium in the treatment of pulmonary arterial hypertension: EPITOME-1 (epoprostenol for injection in pulmonary arterial hypertension), a phase IV, open-label, randomized study

Kelly M. Chin et al.

AMERICAN HEART JOURNAL (2014)

Add to Collection

Review Cardiac & Cardiovascular Systems

Oral Anticoagulation for Pulmonary Arterial Hypertension: Systematic Review and Meta-analysis

Daniel Caldeira et al.

CANADIAN JOURNAL OF CARDIOLOGY (2014)

Add to Collection

Article Cardiac & Cardiovascular Systems

Anticoagulation and Survival in Pulmonary Arterial Hypertension Results From the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)

Karen M. Olsson et al.

CIRCULATION (2014)

Add to Collection

Article Respiratory System

Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study

Olivier Sitbon et al.

EUROPEAN RESPIRATORY JOURNAL (2014)

Add to Collection

Article Cardiac & Cardiovascular Systems

Emotional symptoms and quality of life in patients with pulmonary arterial hypertension

Jasper M. M. Vanhoof et al.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2014)

Add to Collection

Article Critical Care Medicine

Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation

Joshua M. Diamond et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)

Add to Collection

Article Critical Care Medicine

Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients Receiving Background Endothelin Receptor Antagonist and Phosphodiesterase Type 5 Inhibitor Therapy (The FREEDOM-C2 Study) A Randomized Controlled Trial

Victor F. Tapson et al.

CHEST (2013)

Add to Collection

Article Critical Care Medicine

Management of Pulmonary Arterial Hypertension During Pregnancy A Retrospective, Multicenter Experience

Alexander G. Duarte et al.

CHEST (2013)

Add to Collection

Article Cardiac & Cardiovascular Systems

Efficacy and Safety of Oral Treprostinil Monotherapy for the Treatment of Pulmonary Arterial Hypertension A Randomized, Controlled Trial

Zhi-Cheng Jing et al.

CIRCULATION (2013)

Add to Collection

Article Medicine, General & Internal

Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension

Tomas Pulido et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Add to Collection

Article Medicine, General & Internal

Riociguat for the Treatment of Pulmonary Arterial Hypertension

Hossein-Ardeschir Ghofrani et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Add to Collection

Article Respiratory System

Anxiety and depression disorders in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

Dominik Harzheim et al.

RESPIRATORY RESEARCH (2013)

Add to Collection

Review Respiratory System

Understanding the impact of pulmonary arterial hypertension on patients' and carers' lives

Loic Guillevin et al.

EUROPEAN RESPIRATORY REVIEW (2013)

Add to Collection

Article Critical Care Medicine

Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients on Background Endothelin Receptor Antagonist and/or Phosphodiesterase Type 5 Inhibitor Therapy (The FREEDOM-C Study) A Randomized Controlled Trial

Victor E. Tapson et al.

CHEST (2012)

Add to Collection

Article Respiratory System

Pregnancy outcomes in pulmonary arterial hypertension in the modern management era

Xavier Jais et al.

EUROPEAN RESPIRATORY JOURNAL (2012)

Add to Collection

Article Rheumatology

Warfarin in Systemic Sclerosis-associated and Idiopathic Pulmonary Arterial Hypertension. A Bayesian Approach to Evaluating Treatment for Uncommon Disease

Sindhu R. Johnson et al.

JOURNAL OF RHEUMATOLOGY (2012)

Add to Collection

Article Obstetrics & Gynecology

Improved survival in pregnancy and pulmonary hypertension using a multiprofessional approach

D. G. Kiely et al.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2010)

Add to Collection

Article Cardiac & Cardiovascular Systems

Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension

David Montani et al.

EUROPEAN HEART JOURNAL (2010)

Add to Collection

Article Cardiac & Cardiovascular Systems

Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy for pulmonary arterial hypertension: A placebo-controlled trial

Jagdish Hiremath et al.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2010)

Add to Collection

Article Cardiac & Cardiovascular Systems

Addition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial Hypertension A Randomized Controlled Clinical Trial

Vallerie V. McLaughlin et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)

Add to Collection

Article Cardiac & Cardiovascular Systems

Tadalafil Therapy for Pulmonary Arterial Hypertension

Nazzareno Galie et al.

CIRCULATION (2009)

Add to Collection

Review Cardiac & Cardiovascular Systems

Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension?

Elisabeth Bedard et al.

EUROPEAN HEART JOURNAL (2009)

Add to Collection

Article Cardiac & Cardiovascular Systems

Long-Term Ambrisentan Therapy for the Treatment of Pulmonary Arterial Hypertension

Ronald J. Oudiz et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)

Add to Collection

Article Geriatrics & Gerontology

Risk Factors for Community-Acquired Pneumonia in Immunocompetent Seniors

Michael L. Jackson et al.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2009)

Add to Collection

Article Cardiac & Cardiovascular Systems

Ambrisentan for the treatment of pulmonary arterial hypertension -: Results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy (ARIES) Study 1 and 2

Nazzareno Galie et al.

CIRCULATION (2008)

Add to Collection

Article Respiratory System

Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension

R. T. Schermuly et al.

EUROPEAN RESPIRATORY JOURNAL (2008)

Add to Collection

Article Pharmacology & Pharmacy

Pharmacology of Macitentan, an Orally Active Tissue-Targeting Dual Endothelin Receptor Antagonist

Marc Iglarz et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)

Add to Collection

Article Medicine, General & Internal

Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study):: a double-blind, randomised controlled trial

N. Galie et al.

LANCET (2008)

Add to Collection

Article Surgery

Physiologic changes in pregnancy

Christina C. Hill et al.

SURGICAL CLINICS OF NORTH AMERICA (2008)

Add to Collection

Article Respiratory System

Results of European post-marketing surveillance of bosentan in pulmonary hypertension

M. Humbert et al.

EUROPEAN RESPIRATORY JOURNAL (2007)

Add to Collection

Article Critical Care Medicine

Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension

Vallerie V. McLaughlin et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)

Add to Collection

Article Respiratory System

Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension

M. M. Hoeper et al.

EUROPEAN RESPIRATORY JOURNAL (2006)

Add to Collection

Article Critical Care Medicine

Safety and efficacy of IV treprostinil for pulmonary arterial hypertension - A prospective, multicenter, open-label, 12-week trial

VF Tapson et al.

CHEST (2006)

Add to Collection

Article Medicine, General & Internal

Sildenafil citrate therapy for pulmonary arterial hypertension

N Galiè et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Add to Collection

Article Cardiac & Cardiovascular Systems

Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: Definition. A consensus statement of the International Society for Heart and Lung Transplantation

JD Christie et al.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2005)

Add to Collection

Article Cardiac & Cardiovascular Systems

Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension

O Sitbon et al.

CIRCULATION (2005)

Add to Collection

Article Cardiac & Cardiovascular Systems

Antiproliferative effect of sildenafil on human pulmonary artery smooth muscle cells

B Tantini et al.

BASIC RESEARCH IN CARDIOLOGY (2005)

Add to Collection

Article Psychiatry

Anxiety and depression in patients with pulmonary hypertension

B Löwe et al.

PSYCHOSOMATIC MEDICINE (2004)

Add to Collection

Article Medicine, General & Internal

Inhaled iloprost for severe pulmonary hypertension

H Olschewski et al.

NEW ENGLAND JOURNAL OF MEDICINE (2002)

Add to Collection

Article Medicine, General & Internal

Bosentan therapy for pulmonary arterial hypertension

LJ Rubin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2002)

Add to Collection

Article Critical Care Medicine

Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension - A double-blind, randomized, placebo-controlled trial

G Simonneau et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)

Add to Collection

Article Critical Care Medicine

ETA and ETB receptors modulate the proliferation of human pulmonary artery smooth muscle cells

N Davie et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.